-
SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al DC CAFC
- 2:07-cv-05855
- D.N.J.
- Judge: Madeline Cox Arleo
+2
- Filed: 12/07/2007
- Closed: 09/30/2011
- Latest Docket Entry: 10/09/2015
- PACER
4
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
1,394
Days in
Litigation
-
SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al DC CAFC
- 2:07-cv-05855
- D.N.J.
- Judge: Madeline Cox Arleo
+2
- Filed: 12/07/2007
- Closed: 09/30/2011
- Latest Docket Entry: 10/09/2015
- PACER
Market Sector
Biotech and Pharma
Court
Referred Judges
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 3 |
A composition according to claim 1, wherein said ACE inhibitor is 1-ÂN-(1-S-ethoxycarbonyl-3-phenylpropyl)-S-alanyl!-(2S,3aR,7aS)-octahydroÂ1H!indole-2-carboxylic acid (trandolapril) or a physiologically acceptable salt thereof, or
view more
|
Valid (101 and 103)
Entry 319 |
-
Infringement
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Tarka | US 5,721,244 A |
3
|
Infringement
Entry 319
|
Glenmark Pharmaceuticals Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Tarka | US 5,721,244 A |
3
|
Infringement
Entry 319
|
-
Damages
